000294899 001__ 294899
000294899 005__ 20250204094539.0
000294899 0247_ $$2pmid$$apmid:39654522
000294899 0247_ $$2ISSN$$a0020-7136
000294899 0247_ $$2ISSN$$a1097-0215
000294899 0247_ $$2doi$$adoi:10.1002/ijc.35283
000294899 037__ $$aDKFZ-2024-02609
000294899 041__ $$aEnglish
000294899 082__ $$a610
000294899 1001_ $$0P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aFörsti, Asta$$b0$$eFirst author$$udkfz
000294899 245__ $$aSearch for germline gene variants in colorectal cancer families presenting with multiple primary colorectal cancers.
000294899 260__ $$aBognor Regis$$bWiley-Liss$$c2025
000294899 3367_ $$2DRIVER$$aarticle
000294899 3367_ $$2DataCite$$aOutput Types/Journal article
000294899 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1738658695_22142
000294899 3367_ $$2BibTeX$$aARTICLE
000294899 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000294899 3367_ $$00$$2EndNote$$aJournal Article
000294899 500__ $$a#EA:B062# / 2025 Apr 1;156(7):1393-1403
000294899 520__ $$aA double primary colorectal cancer (CRC) in a familial setting signals a high risk of CRC. In order to identify novel CRC susceptibility genes, we whole-exome sequenced germline DNA from nine persons with a double primary CRC and a family history of CRC. The detected variants were processed by bioinformatics filtering and prioritization, including STRING protein-protein interaction and pathway analysis. A total of 150 missense, 19 stop-gain, 22 frameshift and 13 canonical splice site variants fulfilled our filtering criteria. The STRING analysis identified 20 DNA repair/cell cycle proteins as the main cluster, related to genes CHEK2, EXO1, FAAP24, FANCI, MCPH1, POLL, PRC1, RECQL, RECQL5, RRM2, SHCBP1, SMC2, XRCC1, in addition to CDK18, ENDOV, ZW10 and the known mismatch repair genes. Another STRING network included extracellular matrix genes and TGFβ signaling genes. In the nine whole-exome sequenced patients, eight harbored at least two candidate DNA repair/cell cycle/TGFβ signaling gene variants. The number of families is too small to provide evidence for individual variants but, considering the known role of DNA repair/cell cycle genes in CRC, the clustering of multiple deleterious variants in the present families suggests that these, perhaps jointly, contributed to CRC development in these families.
000294899 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000294899 588__ $$aDataset connected to DataCite, PubMed, , Journals: inrepo02.dkfz.de
000294899 650_7 $$2Other$$afamilial colorectal cancer
000294899 650_7 $$2Other$$agermline variant
000294899 650_7 $$2Other$$amultiple primaries
000294899 650_7 $$2Other$$awhole‐exome sequencing
000294899 7001_ $$aAmbrozkiewicz, Filip$$b1
000294899 7001_ $$aMarciniak, Magdalena$$b2
000294899 7001_ $$aLubinski, Jan$$b3
000294899 7001_ $$0P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aHemminki, Kari$$b4$$eLast author$$udkfz
000294899 773__ $$0PERI:(DE-600)1474822-8$$adoi:10.1002/ijc.35283$$n7$$p1393-1403$$tInternational journal of cancer$$v156$$x0020-7136$$y2025
000294899 909CO $$ooai:inrepo02.dkfz.de:294899$$pVDB
000294899 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000294899 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000294899 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000294899 9141_ $$y2024
000294899 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-21$$wger
000294899 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2023-10-21$$wger
000294899 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000294899 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000294899 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000294899 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000294899 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000294899 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000294899 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000294899 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-21
000294899 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000294899 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J CANCER : 2022$$d2023-10-21
000294899 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bINT J CANCER : 2022$$d2023-10-21
000294899 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000294899 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000294899 9201_ $$0I:(DE-He78)Z999-20160331$$kZ999$$lErimitus im DKFZ$$x2
000294899 9200_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000294899 980__ $$ajournal
000294899 980__ $$aVDB
000294899 980__ $$aI:(DE-He78)B062-20160331
000294899 980__ $$aI:(DE-He78)HD01-20160331
000294899 980__ $$aI:(DE-He78)Z999-20160331
000294899 980__ $$aUNRESTRICTED